Evidence map›Paper›PMID 35215231›Full record

ArticlePharmaceuticals (Basel, Switzerland)2022

Evaluation of New Antimicrobial Agents Based on

Alexey S Trenin, Elena B Isakova, Michael I Treshchalin, Vasilisa A Polozkova, Elena P Mirchink, Alexey A Panov, Alexander Y Simonov, Olga P Bychkova, Victor V Tatarskiy, Sergey N Lavrenov

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Comparing LDJournal of chemical health & safety · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Alexey S TreninGause Institute of New Antibiotics, 11 B. Pirogovskaya Street, 119021 Moscow, Russia.
Elena B IsakovaGause Institute of New Antibiotics, 11 B. Pirogovskaya Street, 119021 Moscow, Russia.
Michael I TreshchalinGause Institute of New Antibiotics, 11 B. Pirogovskaya Street, 119021 Moscow, Russia.ORCID 0000-0002-5652-8686
Vasilisa A PolozkovaGause Institute of New Antibiotics, 11 B. Pirogovskaya Street, 119021 Moscow, Russia.
Elena P MirchinkGause Institute of New Antibiotics, 11 B. Pirogovskaya Street, 119021 Moscow, Russia.
Alexey A PanovGause Institute of New Antibiotics, 11 B. Pirogovskaya Street, 119021 Moscow, Russia.
Alexander Y SimonovGause Institute of New Antibiotics, 11 B. Pirogovskaya Street, 119021 Moscow, Russia.
Olga P BychkovaGause Institute of New Antibiotics, 11 B. Pirogovskaya Street, 119021 Moscow, Russia.
Victor V TatarskiyDepartment of Functional Nanosystems and High-Temperature Materials, National University of Science and Technology MISiS, 4 Leninsky Avenue, 119049 Moscow, Russia.ORCID 0000-0002-9080-5683
Sergey N LavrenovGause Institute of New Antibiotics, 11 B. Pirogovskaya Street, 119021 Moscow, Russia.
Gause Institute of New Antibiotics Russian Academy of Medical Sciences · RUNational University of Science and Technology · RU

Funding

Russian Science Foundation 16-15-10300P
6 · The paper itself

Abstract

The antimicrobial activity and toxicity of three novel synthetic antibacterial agents containing

Indexed as

overcoming of drug resistancestaphylococcal sepsistoxicity in vitro and in vivotris(1H-indol-3-yl)methyliumturbomycin

Identifiers

PMID35215231
PMCPMC8878324
OpenAlexW4206070093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.